Not checkedNot checked for notices yet.
Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning
Anne Estrup Olesen, Debbie Grønlund, Mikkel Gram and 3 more
BMC Research Notes · 2018
doi:10.1186/s13104-018-3194-z (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract Objective Use of opioids for pain management has increased over the past decade; however, inadequate analgesic response is common. Genetic variability may be related to opioid efficacy, but due to the many possible combinations and variables, statistical computations may be difficult. This study investigated whether data processing with support vector machine learning could predict required opioid dose in cancer pain patients, using genetic profiling. Eighteen single nucleotide polymorphisms (SNPs) within the µ and δ opioid receptor genes and the catechol-O-methyltransferase gene were selected for analysis. Results Data from 1237 cancer pain patients were included in the analysis. Support vector machine learning did not find any associations between the assessed SNPs and opioid dose in cancer pain patients, and hence, did not provide additional information regarding prediction of required opioid dose using genetic profiling.
Abstract licence: CC BY-NC-ND
References18
18 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.